Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation
The alpha subunit of IL-7 receptor (IL7R7α) is critical for the differentiation of T cells, specifically for the development and maintenance of γδT cells. Mutations in IL7RA are associated with Severe Combined Immunodeficiency (SCID). Infants with IL7RA deficiency can be identified through newborn s...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.01672/full |
id |
doaj-f599f85fc3684f1b96df701ade6f8c09 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Atar Lev Atar Lev Amos J. Simon Amos J. Simon Ortal Barel Ortal Barel Eran Eyal Eran Eyal Eran Eyal Efrat Glick-Saar Efrat Glick-Saar Efrat Glick-Saar Omri Nayshool Omri Nayshool Omri Nayshool Ohad Birk Tali Stauber Amit Hochberg Arnon Broides Shlomo Almashanu Ayal Hendel Yu Nee Lee Yu Nee Lee Raz Somech Raz Somech |
spellingShingle |
Atar Lev Atar Lev Amos J. Simon Amos J. Simon Ortal Barel Ortal Barel Eran Eyal Eran Eyal Eran Eyal Efrat Glick-Saar Efrat Glick-Saar Efrat Glick-Saar Omri Nayshool Omri Nayshool Omri Nayshool Ohad Birk Tali Stauber Amit Hochberg Arnon Broides Shlomo Almashanu Ayal Hendel Yu Nee Lee Yu Nee Lee Raz Somech Raz Somech Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation Frontiers in Immunology IIL7Rα PID SCID NBS TREC immune repertoire |
author_facet |
Atar Lev Atar Lev Amos J. Simon Amos J. Simon Ortal Barel Ortal Barel Eran Eyal Eran Eyal Eran Eyal Efrat Glick-Saar Efrat Glick-Saar Efrat Glick-Saar Omri Nayshool Omri Nayshool Omri Nayshool Ohad Birk Tali Stauber Amit Hochberg Arnon Broides Shlomo Almashanu Ayal Hendel Yu Nee Lee Yu Nee Lee Raz Somech Raz Somech |
author_sort |
Atar Lev |
title |
Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation |
title_short |
Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation |
title_full |
Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation |
title_fullStr |
Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation |
title_full_unstemmed |
Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA Mutation |
title_sort |
reduced function and diversity of t cell repertoire and distinct clinical course in patients with il7ra mutation |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2019-07-01 |
description |
The alpha subunit of IL-7 receptor (IL7R7α) is critical for the differentiation of T cells, specifically for the development and maintenance of γδT cells. Mutations in IL7RA are associated with Severe Combined Immunodeficiency (SCID). Infants with IL7RA deficiency can be identified through newborn screening program. We aimed at defining the immunological and genetic parameters that are directly affected by the IL7RA mutation on the immune system of five unrelated patients which were identified by our newborn screening program for SCID. The patients were found to have a novel identical homozygote mutation in IL7RA (n.c.120 C>G; p.F40L). Both surface expression of IL7Rα and functionality of IL-7 signaling were impaired in patients compared to controls. Structural modeling demonstrated instability of the protein structure due to the mutation. Lastly the TRG immune repertoire of the patients showed reduced diversity, increased clonality and differential CDR3 characteristics. Interestingly, the patients displayed significant different clinical outcome with two displaying severe clinical picture of immunodeficiency and three had spontaneous recovery. Our data supports that the presented IL7RA mutation affects the IL-7 signaling and shaping of the TRG repertoire, reinforcing the role of IL7RA in the immune system, while non-genetic factors may exist that attribute to the ultimate clinical presentation and disease progression. |
topic |
IIL7Rα PID SCID NBS TREC immune repertoire |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2019.01672/full |
work_keys_str_mv |
AT atarlev reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT atarlev reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT amosjsimon reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT amosjsimon reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT ortalbarel reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT ortalbarel reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT eraneyal reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT eraneyal reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT eraneyal reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT efratglicksaar reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT efratglicksaar reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT efratglicksaar reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT omrinayshool reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT omrinayshool reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT omrinayshool reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT ohadbirk reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT talistauber reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT amithochberg reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT arnonbroides reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT shlomoalmashanu reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT ayalhendel reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT yuneelee reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT yuneelee reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT razsomech reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation AT razsomech reducedfunctionanddiversityoftcellrepertoireanddistinctclinicalcourseinpatientswithil7ramutation |
_version_ |
1724868627659751424 |
spelling |
doaj-f599f85fc3684f1b96df701ade6f8c092020-11-25T02:20:57ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-07-011010.3389/fimmu.2019.01672469112Reduced Function and Diversity of T Cell Repertoire and Distinct Clinical Course in Patients With IL7RA MutationAtar Lev0Atar Lev1Amos J. Simon2Amos J. Simon3Ortal Barel4Ortal Barel5Eran Eyal6Eran Eyal7Eran Eyal8Efrat Glick-Saar9Efrat Glick-Saar10Efrat Glick-Saar11Omri Nayshool12Omri Nayshool13Omri Nayshool14Ohad Birk15Tali Stauber16Amit Hochberg17Arnon Broides18Shlomo Almashanu19Ayal Hendel20Yu Nee Lee21Yu Nee Lee22Raz Somech23Raz Somech24The National Lab for Diagnosing SCID - The Israeli Newborn Screening Program, Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Sheba Medical Center, Edmond and Lily Safra Children's Hospital, Israel Ministry of Health, Tel HaShomer, IsraelThe Mina and Everard Goodman Faculty of Life Sciences, Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat-Gan, IsraelSheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelSheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelSheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Wohl Institute for Translational Medicine, Sheba Medical Center, Tel HaShomer, IsraelSheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Wohl Institute for Translational Medicine, Sheba Medical Center, Tel HaShomer, IsraelSheba Cancer Research Center and Institute of Hematology, Sheba Medical Center, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe Wohl Institute for Translational Medicine, Sheba Medical Center, Tel HaShomer, IsraelSoroka Medical Center, Genetics Institute, The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer Sheva, IsraelThe National Lab for Diagnosing SCID - The Israeli Newborn Screening Program, Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Sheba Medical Center, Edmond and Lily Safra Children's Hospital, Israel Ministry of Health, Tel HaShomer, IsraelDepartment of Pediatrics, Hillel Yaffe Medical Center, Hadera, IsraelFaculty of Health Sciences, Soroka University Medical Center, Pediatric Immunology Clinic, Ben-Gurion University of the Negev, Beer Sheva, IsraelThe National Center for Newborn Screening, Israel Ministry of Health, Tel HaShomer, IsraelThe Mina and Everard Goodman Faculty of Life Sciences, Advanced Materials and Nanotechnology Institute, Bar-Ilan University, Ramat-Gan, IsraelThe National Lab for Diagnosing SCID - The Israeli Newborn Screening Program, Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Sheba Medical Center, Edmond and Lily Safra Children's Hospital, Israel Ministry of Health, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe National Lab for Diagnosing SCID - The Israeli Newborn Screening Program, Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, Sheba Medical Center, Edmond and Lily Safra Children's Hospital, Israel Ministry of Health, Tel HaShomer, IsraelSackler Faculty of Medicine, Tel Aviv University, Tel Aviv, IsraelThe alpha subunit of IL-7 receptor (IL7R7α) is critical for the differentiation of T cells, specifically for the development and maintenance of γδT cells. Mutations in IL7RA are associated with Severe Combined Immunodeficiency (SCID). Infants with IL7RA deficiency can be identified through newborn screening program. We aimed at defining the immunological and genetic parameters that are directly affected by the IL7RA mutation on the immune system of five unrelated patients which were identified by our newborn screening program for SCID. The patients were found to have a novel identical homozygote mutation in IL7RA (n.c.120 C>G; p.F40L). Both surface expression of IL7Rα and functionality of IL-7 signaling were impaired in patients compared to controls. Structural modeling demonstrated instability of the protein structure due to the mutation. Lastly the TRG immune repertoire of the patients showed reduced diversity, increased clonality and differential CDR3 characteristics. Interestingly, the patients displayed significant different clinical outcome with two displaying severe clinical picture of immunodeficiency and three had spontaneous recovery. Our data supports that the presented IL7RA mutation affects the IL-7 signaling and shaping of the TRG repertoire, reinforcing the role of IL7RA in the immune system, while non-genetic factors may exist that attribute to the ultimate clinical presentation and disease progression.https://www.frontiersin.org/article/10.3389/fimmu.2019.01672/fullIIL7RαPIDSCIDNBSTRECimmune repertoire |